右美托咪定预处理对脓毒症小鼠肺组织炎症及相关因子表达的影响

doi:10.3969/j.issn.2095-9400.2019.08.008

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1525 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the effect of dexmedetomidine (DEX) on inflammatory reaction and expression of related factors in lung tissues of septic mice stimulated with lipopolysaccharide (LPS). Methods: Male adult C57BL/6 mice were randomly divided into four groups: Control group (group C), Sepsis group (group S), DEX group (group MD) and High dose DEX group (group HD). Group MD and HD were respectively injected DEX solution 25 and 50 μg/kg through tail vein 30 min before modeling, while group C and S were injected equal amount of physiological saline. Septic mice model were then induced by tail vein injection of LPS. Six hours after LPS injection, the protein level of inflammatory cytokines in serum of mice were measured by ELISA kits; Western blot was performed to detect the activity of NF-κB (p65 and IκBα) and AKT. Lung tissues were collected to detect the wet/dry weight ratio (W/D), total lung water content (TLW) and degree of lung tissue injury. Septic model were establised in the same way, mice were monitored every 24 hours and recorded the survival rate for 7 days. Results: Compared with group C, there was a significant elevation in the protein level of TNF-α, CXCL1, CXCL5 and CCL20 (P<0.01) in group S, while DEX can inhibit the level of above-mentioned cytokines. Compared with group S, the pretreatment with DEX can significantly reduce the phosphorylation level of p65, IκBα and AKT (P<0.05), W/D ratio and TLW (P<0.05), and the degree of lung tissue injury. In addition, survival studies indicated that DEX significantly prolonged the survival time of septic mice (P<0.05). Conclusion: Pretreatment with DEX may protect lung tissues in septic mice by reducing the expression of AKT and NF-κB, and inhibiting the expression of inflammatory cytokines.

Key words： dexmedetomidine sepsis lipopolysaccharide lung tissue inflammation mice

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LU Guangtao
	LIN Xuezheng
	YAO Zhangquan
	WANG Junlu

URL:

https://xb.wmu.edu.cn/EN/10.3969/j.issn.2095-9400.2019.08.008 OR https://xb.wmu.edu.cn/EN/Y2019/V49/I8/589

[1] 张莹, 马晓媛, 梁华平. 抗菌药物在脓毒症中的应用进展[J]. 中华危重病急救医学, 2015, 27(9): 773-776.
[2] 吴晓飞. 脓毒症的诊断和治疗[J]. 中华全科医学, 2014, 12(10): 1538-1539.
[3] ZHANG J, WANG Z, WANG Y, et al. The effect of dexmedetomidine on inflammatory response of septic rats[J]. BMC Anesthesiol, 2015, 15: 68.
[4] 邓丽静, 王岚, 王波, 等. 右美托咪定对脓毒症大鼠炎症反应和淋巴细胞凋亡的影响[J]. 中华危重病急救医学, 2012, 24(9): 558-561.
[5] 周少丽, 谭芳, 陈裕洁. 右美托咪定用于治疗脓毒症的研究及其进展[J]. 实用医学杂志, 2013, 29(15): 2421-2422.
[6] KAWASAKI T, KAWASAKI C, UEKI M, et al. Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro[J]. J Trauma Acute Care Surg, 2013, 74 (5): 1370-1375.
[7] 蔡玥娇, 刘华跃, 钟丽敏, 等. 右美托咪定对脓毒症大鼠脑组织炎性反应的影响[J]. 中华麻醉学杂志, 2013, 33(6): 749-751.
[8] HU H, SHI D, HU C, et al. Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway[J]. Am J Transl Res, 2017, 9(12): 5245-5258.
[9] 庞凌霄, 蔡文伟, 张美齐, 等. 右美托咪定对脓毒症患者免疫调节的影响研究[J]. 中华医院感染学杂志, 2018, 28(12): 1791-1794.
[10] JIN Y, QIAN J, JU X, et al. Osthole protects against acute lung injury by suppressing NF-κB-dependent inflamma-tion[J]. Mediators Inflamm, 2018, 2018: 4934592.
[11] LIU Z, WANG Y, WANG Y, et al. Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway[J]. Int Immunopharmacol, 2016, 35: 210-216.
[12] 李欣, 李景辉, 苏醒, 等. 右美托咪定对脓毒症大鼠炎症介质的影响[J]. 中华急诊医学杂志, 2015, 24(8): 834-838.
[13] KONG W, KANG K, GAO Y, et al. Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice[J]. Am J Transl Res, 2017, 9(11): 5040-5047.
[14] GIROLOMONI G, MROWIETZ U, PAUL C. Psoriasis: rationale for targeting interleukin-17[J]. Br J Dermatol, 2012, 167(4): 717-724.
[15] LI D, WANG A, LIU X, et al. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing[J]. J Clin Invest, 2015, 125(8): 3008-3026.
[16] 纪木火, 吴晶, 李仁奇, 等. 右旋美托咪啶对脓毒血症大鼠急性肺损伤的影响[J]. 中华临床医师杂志(电子版), 2011, 5(21): 6434-6436.
[17] 尹承芬, 龚平, 姚咏明. 胆碱能抗炎通路对脓毒症时免疫反应的影响及其调节机制[J]. 中华实验外科杂志, 2012, 29(11): 2337-2338
[18] 彭文勇, 屠文龙, 乐新会, 等. 右美托咪定对重度颅脑损伤患者血清内脂素和高敏C-反应蛋白的影响[J]. 温州医科大学学报, 2015, 45(2): 126-130.
[19] 吴叶林, 全艳春, 赖玉平. 角质形成细胞与T细胞的cross-talk诱发银屑病的研究现状及展望[J]. 生命科学, 2016, 28(2): 258-267.
[20] 张珣, 唐莎, 袁琳, 等. 气道上皮趋化因子与肺部炎症反应的研究进展[J]. 广东医学, 2018, 39(21): 3277-3282.